RWA Wealth Partners’s DexCom DXCM Stock Holding History

RWA Wealth Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,611	Closed	-$228K	–	618
2025 Q2	$228K	Buy	+2,611	New	+$205K	﹤0.01%	555
2025 Q1	–	Sell	-2,969	Closed	-$231K	–	553
2024 Q4	$231K	Buy	+2,969	New	+$220K	﹤0.01%	524

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RWA Wealth Partners's DXCM Position: Q3 2025 in Review

RWA Wealth Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,611 shares — an estimated $228K sold.

RWA Wealth Partners first reported a position in DXCM in Q4 2024 and held it in 2 quarters. The position peaked at $231K in Q4 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

RWA Wealth Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
RWA Wealth Partners sold 2,611 DexCom shares in Q3 2025, an estimated $228K.
RWA Wealth Partners first reported a position in DexCom in Q4 2024 and held it in 2 quarters.
RWA Wealth Partners's DexCom position peaked at $231K in Q4 2024.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on RWA Wealth Partners's 13F filing for Q3 2025, filed 10 Nov 2025.